logo
ARCTIC BLUE DIAMONDS ACQUIRES CONTROLLING INTEREST IN WO DIAMOND PROJECT HOSTING THE DO27 KIMBERLITE

ARCTIC BLUE DIAMONDS ACQUIRES CONTROLLING INTEREST IN WO DIAMOND PROJECT HOSTING THE DO27 KIMBERLITE

Cision Canada09-07-2025
YELLOWKNIFE, NT, July 9, 2025 /CNW/ - Arctic Blue Diamonds Ltd. ("Arctic Blue"), a private NWT diamond company, today announced the acquisition of an 89.7 percent interest in the WO Diamond Project, which hosts the large, high-grade DO27 kimberlite. A 72.1 percent interest was acquired from Peregrine Diamonds Ltd., a subsidiary of De Beers Canada Inc., and a further 17.6 percent interest was acquired from Archon Minerals Ltd.
Arctic Blue is part of the Arctic Blue Group, which includes Arctic Blue LLC, an online diamond jewelry retailer offering a large selection of Canadian fluorescent diamonds on arcticblue.com. As operator of the WO Joint Venture ("WO JV"), Arctic Blue holds the diamond marketing rights of future diamond production.
The WO Project encompasses eight mining leases covering 5,815 hectares located approx. 11 kilometers (km) off the seasonal ice road, 23km from the Diavik Diamond Mine and 53km from the Ekati Diamond Mine.
DO27 is one of the largest diamond-bearing kimberlites in Canada. The pipe has a surface area of approx. 9 hectares and lies below a shallow lake with an area of approx. 1 square km and an average depth of approx. 4 meters (m). By comparison, all the kimberlites mined at the Diavik Diamond Mine have surface areas less than 2 hectares, and most of the kimberlites at the Ekati Diamond Mine have surface areas less than 3 hectares.
Extensive delineation and resource drilling has been undertaken at DO27, including 114 core holes (24,185m) and 46 large diameter reverse circulation holes (8,840m). DO27 has been explored in detail to a depth of approx. 350m and remains open further to depth.
Based on drilling completed to date, the DO27 kimberlite hosts the following Mineral Resources:
Notes:
-
Effective data is August 7, 2008
-
Dr. Ted Eggleston, RM SME and Ken Brisebois, P.Eng. are the Qualified Persons for the estimate.
-
Mineral Resources are stated at an effective 1mm bottom cutoff and are constrained within a conceptual mining shell based on assumptions of a diamond price of US$72/carat, 100% metallurgical recovery, US$2.05/t mining costs with an incremental $0.02 per 10m depth, US$19.96/t operating costs including on-site scrubbing and an estimate for trucking to, and processing at, an off-site diamond processing facility.
At depth, beneath the Indicated Mineral Resource, an additional 6.5-8.5 million tonnes of kimberlite grading in the range of 0.8-1.0 carats per tonnes (cpt) represents a target for further exploration. The potential quantity and grade of this target is conceptual in nature. Further resource drilling will be required to define an expanded mineral resource. It is uncertain whether additional exploration will result in the target being delineated as a mineral resource.
Independent valuations of diamonds recovered from DO27 were conducted in 2006 and 2007 by WWW International Diamond Consultants Ltd. ("WWW"). The 2007 valuation was based on a parcel of 2,075 carats. The DO27 Mineral Resource declared in 2008 assumed an average rough diamond price of US$72 per carat. In July 2014, WWW provided a report showing a general upward trend of rough diamond prices since the 2007 valuation. Based on independent rough diamond price indices, the average rough diamond price for the DO27 parcel is now projected to have increased to between US$90 and US$100 per carat.
Unlike most kimberlites, the DO27 ore is extremely soft with a very low density. Based on this, Peregrine Diamonds retained AMEC Americas Ltd. to develop an Ore Concentrate Option whereby a simple ore washing process removes high quantities of unwanted fines fractions below 1mm and retains the +1mm ore fractions for final processing at an off-site diamond recovery plant. Testing of the DO27 kimberlite confirmed that approx. 90 percent of the ore in the first 60m depth interval will report to fines after the washing process. This significantly reduces the volume of diamond-bearing ore to be transported to an off-site diamond plant.
Arctic Blue Executive Chair Patrick Evans commented: "As some of the existing diamond mines approach the end of their economic lives, DO27 offers the opportunity to extend the life of the existing diamond plants by producing a very high-grade diamond concentrate of over 80 carats per tonne suitable for shipment to existing diamond recovery facilities, or alternatively to a purpose-built facility in Yellowknife."
Mr. Evans added: "The extremely soft nature of the DO27 ore also opens the potential for the deployment of Underwater Remote Mining (URM) technology. Kimberlites with soft, low-density ore can be mined most efficiently using URM systems. Besides offering exceptionally low capital and operating cost opportunities, URM is the most sustainable form of mining, with minimal impact on the environment."
The URM system for kimberlites was developed by IHC Mining, a division of Royal IHC ("IHC") of The Netherlands, and is based on decades of deep-sea mining and trenching experience. In 2018, Dominion Diamond Mines contracted IHC to develop a URM system for deployment at the Ekati Diamond Mine in Canada's Northwest Territories. Over the past seven years, various elements of URM systems have been tested, and capital and operating costs have been modeled. The test results confirmed that the most suitable system for underwater kimberlite mining is the "Crawler" system.
As announced by IHC Mining on September 14, 2022: "The underwater mining crawler is a remote operated continuous mining machine, equipped with the latest underwater control and positioning equipment. The ore is directly excavated with a drum cutter in small layers and eliminates the need for blasting explosives. From the crawler, the ore is pumped to the surface of the flooded pit via a vertical pipeline system to the Launch and Recovery Platform, from where the ore is transported further to a dewatering plant. The crawler system is capable of operating at a water depth of up to 400 meters."
The Ekati Diamond Mine's first mining crawler has been built at IHC's facility in the United Kingdom.
While the WO Project remains on care and maintenance, environmental, geological, and engineering studies will be undertaken to assess development opportunities for the DO27 kimberlite, including the potential for deployment of URM technology and production of a high-grade diamond concentrate for offsite treatment and final diamond recovery.
About Arctic Blue Diamonds Ltd.
Arctic Blue Diamonds Ltd. is a private NWT corporation focused on the development of the DO27 kimberlite in Canada's Northwest Territories www.arcticblue.com.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

How major US stock indexes fared Wednesday, 8/13/2025
How major US stock indexes fared Wednesday, 8/13/2025

Globe and Mail

time4 hours ago

  • Globe and Mail

How major US stock indexes fared Wednesday, 8/13/2025

U.S. stocks notched some more records as a rally spurred by hopes for lower U.S. interest rates wrapped around the world. The S&P 500 rose 0.3% Wednesday. The Dow Jones Industrial Average climbed 1%, while the Nasdaq added 0.1% to its record set the day before. Treasury yields eased, as expectations reached a virtual consensus that the Federal Reserve will cut its main interest rate for the first time this year at its next meeting in September. On Wednesday: The S&P 500 rose 20.82 points, or 0.3%, to 6,466.58. The Dow Jones Industrial Average rose 463.66 points, or 1%, to 44,922.27. The Nasdaq composite rose 31.24 points, or 0.1%, to 21,713.14. The Russell 2000 index of smaller companies rose 45.28 points, or 2%, to 2,228.06. For the week: The S&P 500 is up 77.13 points, or 1.2%. The Dow is up 746.66 points, or 1.7%. The Nasdaq is up 263.12 points, or 1.2%. The Russell 2000 is up 109.64 points, or 4.9%. For the year: The S&P 500 is up 584.95 points, or 9.9%. The Dow is up 2,378.05 points, or 5.6%. The Nasdaq is up 2,402.35 points, or 12.4%. The Russell 2000 is up 97.90 points, or 4.4%.

Media advisory - Canada and Sweden advance their collaboration Français
Media advisory - Canada and Sweden advance their collaboration Français

Cision Canada

time5 hours ago

  • Cision Canada

Media advisory - Canada and Sweden advance their collaboration Français

STOCKHOLM, Sweden, Aug. 15, 2025 /CNW/ - The Honourable Mélanie Joly, Minister of Industry and Minister responsible for Canada Economic Development for Quebec Regions, will meet with Ebba Busch, Sweden's Deputy Prime Minister and Minister for Energy, Business and Industry in Stockholm to deepen Canada–Sweden relationship. They will be joined by the Honourable Stephen Fuhr, Secretary of State (Defence Procurement), and Pål Jonson, Sweden's Minister for Defence. Date: Monday, August 18, 2025 Time: 8:30 p.m. (Central European Time) Location: Stockholm, Sweden Note to media: This is a media spray only. Photo and video opportunity will be available at the top of the meeting. Members of the media are asked to contact Isabella Orozco-Madison at [email protected] to receive event location details and confirm their attendance. Stay connected SOURCE Innovation, Science and Economic Development Canada

ZYUS Life Sciences Announces Closing of Second Tranche of Unit Offering
ZYUS Life Sciences Announces Closing of Second Tranche of Unit Offering

Cision Canada

time5 hours ago

  • Cision Canada

ZYUS Life Sciences Announces Closing of Second Tranche of Unit Offering

SASKATOON, SK, Aug. 15, 2025 /CNW/ - ZYUS Life Sciences Corporation (the " Company") (TSXV: ZYUS), a Canadian-based life sciences company focused on the development and commercialization of novel cannabinoid-based pharmaceutical drug candidates for pain management, is pleased to announce that, further to its press release dated July 29, 2025, it has closed the second tranche (the " Second Tranche") of its non-brokered private placement (the " Offering") of units of the Company (each a " Unit") for up to CAD $1,000,000. Under the Second Tranche of the Offering, a further 140,845 Units were issued for aggregate gross proceeds of CAD $100,000. The aggregate gross proceeds raised in the Second Tranche and first tranche of the Offering (which closed on July 29, 2025) (the " First Tranche") is approximately $0.42 million. The Company has issued a total of 591,126 Units each priced at $0.71 per Unit in the First Tranche and the Second Tranche. Each Unit consists of one common share of the Company (a " Common Share") and one Common Share purchase warrant (each Common Share purchase warrant, a " Warrant"), whereby each Warrant entitles the holder to acquire one Common Share at a price of $0.95 for a period of twenty-four months from the date of issuance, unless the term of the Warrant is accelerated pursuant to its terms (the " Acceleration Provision"). In accordance with the Acceleration Provision, if the volume-weighted average trading price of the Common Shares is greater than $3.00 for a period of 5 consecutive trading days on the TSX Venture Exchange (the " TSXV"), the Company will have the right to accelerate the expiry date of the Warrants. Proceeds of the Offering will be used for general corporate and working capital purposes. No finder's fees were paid in connection with the Offering. The Units were offered by way of private placement pursuant to exemptions from prospectus requirements under applicable securities laws. All securities issued under the First Tranche are subject to a hold period expiring November 30, 2025, and all securities issued under the Second Tranche of the Offering are subject to a hold period expiring December 16, 2025, in accordance with applicable securities laws and the policies of the TSXV. The Offering has received conditional approval from the TSXV and remains subject to final acceptance of the TSXV. The securities described herein have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the " U.S. Securities Act"), or any state securities laws, and may not be offered or sold within the United States or to, or for account or benefit of, U.S. persons except in compliance with the registration requirements of the U.S. Securities Act and applicable state securities laws or pursuant to available exemptions therefrom. This release does not constitute an offer to sell or a solicitation of an offer to buy of any securities in the United States. About ZYUS Life Sciences Corporation ZYUS (TSXV: ZYUS) is a life sciences company focused on the development and commercialization of novel cannabinoid-based pharmaceutical drug candidates for pain management. Through rigorous scientific exploration and clinical research, ZYUS aims to secure intellectual property protection, safeguarding its innovative therapies and bolstering shareholder value. ZYUS' unwavering commitment extends to obtaining regulatory approval of non-opioid-based pharmaceutical solutions, in pursuit of transformational impact on patients' lives. For additional information, visit or follow us on X @ZYUSCorp. Cautionary Note Regarding Forward-Looking Statements This news release contains "forward-looking information" within the meaning of applicable securities laws relating to the Company's business, the Company's ability to advance clinical research activities, obtain regulatory approval of cannabinoid-based pharmaceutical drug candidates and introduce products that act as alternatives to current pain management therapies such as opioids, receipt of TSXV final acceptance, closing of any additional tranche of the Offering and use of proceeds from the Offering. Any such forward-looking statements may be identified by words such as "expects", "anticipates", "intends", "contemplates", "believes", "projects", "plans", "will" and similar expressions. Readers are cautioned not to place undue reliance on forward-looking statements. Statements about, among other things, the Company's business, the Company's ability to advance clinical research activities, obtain regulatory approval of cannabinoid-based pharmaceutical drug candidates and introduce products that act as alternatives to current pain management therapies such as opioids, obtain TSXV final acceptance, closing of any additional tranche of the Offering and use of proceeds from the Offering are all forward-looking information. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management's reasonable assumptions, there can be no assurance that the Company will be able to achieve these results. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances or actual results unless required by applicable law. Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this press release.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store